BayBio, the life-sciences industry group for the San Francisco Bay Area and northern California, has completed the move of its staff and offices within South San Francisco, Calif.
The group is now based within 6,920 square feet at 400 Oyster Point Blvd., about double the size of BayBio's previous offices at 395 Oyster Point Blvd.
Matthew Gardner, BayBio's president and CEO, was unpacking boxes when he told BioRegion News earlier this month that the new office will allow BayBio to "add to the staff here, and continue to add to our services to the industry."
According to Gardner, BayBio's membership has risen from 196 when he started at his current position Jan. 1, 2004, to about 500. Staff has grown during that time from four to 14 employees.
"We, right now, are focusing on adding to member services in order to improve how we deliver bottom-line benefits to members. So that staff will grow as those services build," Gardner said.
Staff is also likely to grow, he added, as BayBio expands its menu of grant-funded activities. "We're exploring increased science-education activities, and increased entrepreneurial activities. Some of those programs depend on where industry leadership wants us to direct our energies."
BayBio is subleasing part of the 25,288-square-foot former headquarters of Novacea, which vacated the space after merging with Transcept Pharmaceuticals of Port Richmond, Calif.
Transcept disclosed the sublease in a June 18 filing with the US Securities and Exchange Commission. According to the filing, BayBio — formally known as the Bay Area Bioscience Association — agreed to lease the space from July of this year through Oct. 31, 2012, at a total base rent of approximately $367,000 for the lease term, plus a $12,500 security deposit.
BayBio "does not have the option of extending the term of the sublease," Transcept disclosed.